Literature DB >> 27623720

Evaluation of two injection sclerosants in the treatment of symptomatic haemorrhoids in Nigerians.

Cathlyn Akindiose1, Olusegun Isaac Alatise2, Olukayode Adeolu Arowolo2, Augustine E Agbakwuru2.   

Abstract

OBJECTIVES: The objective of this study was to compare the efficacy and safety of 5% phenol in almond oil with 50% dextrose water as sclerosants in the treatment of first- to third-degree haemorrhoids. PATIENTS AND METHODS: This was a prospective, comparative study conducted on eighty patients with first-, second- and third-degree haemorrhoids who consented to treatment by injection sclerotherapy with either 5% phenol in almond oil or 50% dextrose water. They were randomised equally into two groups.
RESULTS: A total of eighty patients including 58 males and 22 females whose age ranged from 19 to 61 years were included in the study. Bleeding was the chief symptom which was present in 78 (97.5%) patients, and there was complete resolution of this in 92.3% and 89.7% in the 5% phenol in almond oil and 50% dextrose water groups, respectively, at 6 months (P = 0.905). Similar degrees of resolution were noted for anal protrusion (89.1% and 85.3% in the 5% phenol in almond oil and 50% dextrose water group, respectively, P = 0.899). The overall complication rate was 3.6% with anal mucosa ulceration being the only complication, occurring in three patients who had 5% phenol in almond oil. Peri-procedure pain, patients satisfaction and acceptability were not significantly different in both groups (P = 0.912, 0.928 and 0.926 respectively).
CONCLUSION: Five percent phenol in almond oil and 50% dextrose water are equally effective sclerosants in the treatment of haemorrhoids with very low complication rates.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27623720     DOI: 10.4103/1117-1936.190347

Source DB:  PubMed          Journal:  Niger Postgrad Med J


  7 in total

1.  Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial.

Authors:  Sandeep Mishra; Ashok Kumar Sahoo; Thirthar Palanivelu Elamurugan; Sadasivan Jagdish
Journal:  Turk J Gastroenterol       Date:  2020-05       Impact factor: 1.852

2.  Hemorrhoidal disease: Predilection sites, pattern of presentation, and treatment.

Authors:  Emeka Ray-Offor; Solomon Amadi
Journal:  Ann Afr Med       Date:  2019 Jan-Mar

Review 3.  Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease.

Authors:  G Gallo; J Martellucci; A Sturiale; G Clerico; G Milito; F Marino; G Cocorullo; P Giordano; M Mistrangelo; M Trompetto
Journal:  Tech Coloproctol       Date:  2020-01-28       Impact factor: 3.781

Review 4.  Progress in Endoscopic Treatment of Hemorrhoids.

Authors:  Wenzhuang Ma; Jintao Guo; Fan Yang; Christoph F Dietrich; Siyu Sun
Journal:  J Transl Int Med       Date:  2020-12-31

Review 5.  A Stepwise Proposal for Low-Grade Hemorrhoidal Disease: Injection Sclerotherapy as a First-Line Treatment and Rubber Band Ligation for Persistent Relapses.

Authors:  Roberta Tutino; Marco Massani; Leonel Jospin Kamdem Mambou; Paolina Venturelli; Immacolata Della Valle; Giuseppina Melfa; Matilde Micheli; Gaia Russo; Gregorio Scerrino; Sebastiano Bonventre; Gianfranco Cocorullo
Journal:  Front Surg       Date:  2022-01-10

6.  Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes.

Authors:  Francesco Pata; Luigi Maria Bracchitta; Giancarlo D'Ambrosio; Salvatore Bracchitta
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

7.  Acute Severe Lower Gastrointestinal Bleeding in Low- and Medium-Income Countries: An Approach to Management of Two Cases and the Need for Local Guidelines.

Authors:  Adedire T Adenuga
Journal:  Cureus       Date:  2022-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.